Silicon Canals
TRENDING
  • Mobility
  • AI
  • FinTech
  • Software & SaaS
No Result
View All Result
  • Home
  • News
    • COVID-19
    • Startups
    • Scaleups
    • FinTech
    • AI and chatbots
    • Travel & Mobility
    • Software & SaaS
    • Health & Medtech
    • (Crowd)funding
    • Blockchain
    • Internet of things
    • Hardware
    • Accelerators
    • E-commerce
    • Cybersecurity
    • Gaming & Virtual Reality
    • Drones
  • Features
    • Promoted content
    • How-to
    • Knowledge & Insights
    • Guest Contributions
    • Scaling-up in Europe
  • Amsterdampartner
  • Events
  • Jobs
  • Partner with us
  • About us
    • About
    • Contact
    • Newsletter
    • Team
  • Home
  • News
    • COVID-19
    • Startups
    • Scaleups
    • FinTech
    • AI and chatbots
    • Travel & Mobility
    • Software & SaaS
    • Health & Medtech
    • (Crowd)funding
    • Blockchain
    • Internet of things
    • Hardware
    • Accelerators
    • E-commerce
    • Cybersecurity
    • Gaming & Virtual Reality
    • Drones
  • Features
    • Promoted content
    • How-to
    • Knowledge & Insights
    • Guest Contributions
    • Scaling-up in Europe
  • Amsterdampartner
  • Events
  • Jobs
  • Partner with us
  • About us
    • About
    • Contact
    • Newsletter
    • Team
No Result
View All Result
Silicon Canals
No Result
View All Result

This Irish startup secures €2.35M to visualise virally infected cells in great detail

Editorial team by Editorial team
October 12, 2020
in (Crowd)funding, COVID-19, Health & Medtech, News, Startups
0
This Irish startup secures €2.35M to visualise virally infected cells in great detail
42
SHARES
LinkedInTwitterWhatsAppFacebook

To date, the origin of viruses remains murky for cell biologists and virologists. And the fact it replicates itself within the cells it invades makes it even more difficult for scientists to classify it, as per the biological classification. Numerous scientists around the world are putting the pieces together, based on viral histories, in a bid to trace the origin of the viruses. 

In this regard, SiriusXT, a University College Dublin (UCD) spin-out, and two UCD researchers are working on a 4-year CoCID (Compact Cell-Imaging Device) project. The mission of the project is to provide insights into the cellular origins of viral diseases like hepatitis C, hepatitis E, herpesvirus, and SARS-CoV-2. 

Raised €2.35M in funding

Recently, SiriusXT has been awarded a total of €2.35M in funding for a disruptive photonics technology project through Horizon 2020, the EU’s research and innovation programme. Co-founded by Dr. Kenneth Fahy, Dr. Paul Sheridan, Dr. Fergal O’Reilly, and Tony McEnroe in 2015, SiriusXT has now raised over €12M in grant and equity funding.

Notably, SiriusXT and the UCD researchers – Assistant Professor Nicola Fletcher and Professor Dimitri Scholz, are partners in an international project, CoCID, which has received a total of €5.67M in funding.

Helps scientists to understand diseases

The 3D imaging of the internal structure of the whole and intact cells is playing an important role in helping scientists to understand diseases, since it plays a major role in cell signalling mechanisms that underpin disease causation. 

Based on research carried out at the UCD School of Physics, SiriusXT has developed and patented a miniaturised soft x-ray source – Soft X-Ray Microscope. The core technology, underpinning the SiriusXT microscope is a vacuum-based laser-produced plasma (LPP) soft x-ray light source.

In simple words, it is essentially a CT scan of the cell and it is critical to life scientists looking to image the 3D internal structure of an entire cell in its native fully hydrated state.

According to SiriusXT, this breakthrough is significantly impacting the cell imaging market by opening up access for a proven imaging modality to thousands of disease researchers worldwide including those partnering in the CoCID project.

Tony McEnroe, CEO and co-founder, SiriusXT, says, “This project award not only helps fund the advancement of our SXT-100 microscope, it also allows SiriusXT to collaborate closely with European leaders in virology research to demonstrate the benefits of soft x-ray microscopy in progressing their understanding of pathogen infection pathways.”

Early access to soft x-ray microscope

Through the CoCID project, UCD researchers gain early access to the SiriusXT soft x-ray microscope as part of the core imaging facility at the UCD Conway Institute. Besides, assistant professor Nicola Fletcher will use the soft x-ray microscopy as one of the four CoCID use cases to accelerate research studies into understanding cross-species transmission mechanisms of the hepatitis E virus.

Assistant Professor Nicola Fletcher, UCD School of Veterinary Medicine, says, “Soft x-ray microscopy is an extremely exciting, potentially game-changing technique that will allow us to visualise virally infected cells in exquisite detail. We will investigate the mechanisms by which the hepatitis E virus, an emerging infectious disease that is transmitted to humans from infected animals, infects cells from different species. The ultimate aim is to explore new treatment options for this important viral infection.”

Partners of CoCID projects

Apart from SiriusXT and UCD, the other CoCID project partners are – Heidelberg University Hospital Molecular Virology and Heidelberg University Centre for Organismal Studies in Germany, University of Jyväskylä, Finland; Centro Nacional de Biotecnologia and Alba Synchrotron – Mistral Beamline in Spain.

Featured image credits: creativeneko/Shutterstock

close

Want to stay on top of the latest rounds, coolest tech and hottest startups?

Subscribe to our free, daily news blast and stay up-to-date!

Check your inbox or spam folder to confirm your subscription.

 - Partner content -
Future Hamburg Award 2021
Future Hamburg Award 2021
Call for startups with innovative solutions for the future cities from all over the globe.
Call for startups with innovative solutions for the future cities from all over the globe. Show Less
Read more
Tags: fundinghealthtechstartups
Share3Tweet11SendShare17

Featured events

Current Month

april

No Events

Partner content | Work with us

Amsterdam-based Lumicks raises €77.6M to provide instruments to reveal unique molecular, cellular interactions

Calling all European deep-tech scaleups: EIT Digital Challenge 2021 registration is now open

Amsterdam-based SaaS startup SwipeGuide raises €5M for international expansion; aims to double its staff in 2021

Innovation against climate change: what Blue Tulip Awards’ experts on Climate & Energy are looking for

Blue Tulip Awards’ experts of Finance & Prosperity: why COVID, regulations and digitisation boost innovation

Silicon Canals Jobs


Breaking news from Amsterdam | Partner

How to find your way in Amsterdam’s alternative funding jungle: An interview with Renée Andela of KplusV

Amsterdam’s test automation startup SEGRON raises funding; looks to increase workforce by 30% by 2021-end

After tripling its revenue in 2020, Amsterdam-based fashion e-commerce startup Otrium raises €102.3M

Amsterdam’s IoT spacetech startup Hiber raises €26M to expand the world’s first global IoT satellite network

  • About Silicon Canals
  • Partner with Silicon Canals
  • Contact us
  • Newsletter
  • Disclaimer
  • Privacy policy
  • Terms & Conditions Silicon Canals

Silicon Canals 2014-2020 | Website: Bright Idiots

No Result
View All Result
  • Home
  • News
    • COVID-19
    • Startups
    • Scaleups
    • FinTech
    • AI and chatbots
    • Travel & Mobility
    • Software & SaaS
    • Health & Medtech
    • (Crowd)funding
    • Blockchain
    • Internet of things
    • Hardware
    • Accelerators
    • E-commerce
    • Cybersecurity
    • Gaming & Virtual Reality
    • Drones
  • Features
    • Promoted content
    • How-to
    • Knowledge & Insights
    • Guest Contributions
    • Scaling-up in Europe
  • Amsterdam
  • Events
  • Jobs
  • Partner with us
  • About us
    • About
    • Contact
    • Newsletter
    • Team

Silicon Canals 2014-2020 | Website: Bright Idiots

X

This website uses cookies to ensure the best possible experience. We may share this information with our advertising and analytics partners. By clicking 'Accept', you agree to our use of cookies and similar technologies. More info